Tumor-cell targeting polydiacetylene micelles encapsulated with an antitumor drug for the treatment of ovarian cancer-Reference-Cited by-同舟云学术

Tumor-cell targeting polydiacetylene micelles encapsulated with an antitumor drug for the treatment of ovarian cancer

Published:2017 Issue:7 Volume:53 Page:1233-1236
ISSN:1359-7345
Container-title:Chemical Communications
language:en
Short-container-title:Chem. Commun.

Author:

Yao Defan¹²³⁴,Li Shang¹²³⁴,Zhu Xiaomin¹²³⁴,Wu Junchen¹²³⁴,Tian He¹²³⁴

Affiliation:

1. Key Labs for Advanced Materials and Institute of Fine Chemicals

2. East China University of Science and Technology

3. Shanghai 200237

4. China

Abstract

Peptide-functionalized sub-30 nm PDA micelles penetrate efficiently into a tumor for enhanced therapeutic efficacy.

Publisher

Royal Society of Chemistry (RSC)

Subject

Materials Chemistry,Metals and Alloys,Surfaces, Coatings and Films,General Chemistry,Ceramics and Composites,Electronic, Optical and Magnetic Materials,Catalysis

Link

http://pubs.rsc.org/en/content/articlepdf/2017/CC/C6CC08581D

Reference32 articles.

1. Ovarian cancer: strategies for overcoming resistance to chemotherapy

2. Early Detection of Ovarian Cancer

3. Dual-Pore Mesoporous Carbon@Silica Composite Core-Shell Nanospheres for Multidrug Delivery

4. Molecularly Precise Dendrimer-Drug Conjugates with Tunable Drug Release for Cancer Therapy

5. Well-Defined, Reversible Boronate Crosslinked Nanocarriers for Targeted Drug Delivery in Response to Acidic pH Values andcis-Diols

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymeric Micellar Systems—A Special Emphasis on “Smart” Drug Delivery;Pharmaceutics;2023-03-17

2. Nanoencapsulated Systems for Delivery of Phytopharmaceuticals;Advances in Novel Formulations for Drug Delivery;2023-02-07

3. Advancements in Polymeric Nanocarriers to Mediate Targeted Therapy against Triple-Negative Breast Cancer;Pharmaceutics;2022-11-10

4. Recent advances in developing polymeric micelles for treating cancer: Breakthroughs and bottlenecks in their clinical translation;Drug Discovery Today;2022-05

5. Nanocarriers for the Molecular Targeting of Pathogenic Bacteria;Alternatives to Antibiotics;2022